References

  1. Badial RM, Dias MC, Stuqui B, dos Santos Melli PP, Quintana SM, do Bonfim CM et al. Detection and genotyping of human papillomavirus (HPV) in HIV-infected women and its relationship with HPV/HIV co-infection. Medicine (Baltimore). 2018 Apr;97(14):e9545. PubMed | Google Scholar

  2. Ermel A, Qadadri B, Tong Y, Orang'o O, Macharia B, Ramogola-Masire D et al. Invasive cervical cancers in the United States, Botswana and Kenya: HPV type distribution and health policy implications. Infect Agent Cancer. 2016 Nov 11;11:56. eCollection 2016. PubMed | Google Scholar

  3. Verma M, Erwin S, Abedi V, Hontecillas R, Hoops S, Leber A et al. Modeling the mechanisms by which HIV-associated immunosuppression influences HPV persistence at the oral mucosa. PloS One. 2017;12(1):e016813. PubMed | Google Scholar

  4. Mwakigonja AR, Torres LMM, Mwakyoma HA, Kaaya EE. Cervical cytological changes in HIV-infected patients attending care and treatment clinic at Muhimbili National Hospital, Dar es Salaam, Tanzania. Infect Agent Cancer. 2012 Feb 15;7:3. PubMed | Google Scholar

  5. Maranga IO, Hampson L, Oliver AW, He X, Gichangi P, Rana F et al. HIV infection alters the spectrum of HPV subtypes found in cervical smears and carcinomas from Kenyan women. Open Virol J. 2013;7:19-27. PubMed | Google Scholar

  6. Korir A, Okerosi N, Ronoh V, Mutuma G, Parkin M. Incidence of cancer in N airobi, K enya (2004-2008). Int J Cancer. 2015;137(9):2053-2059. PubMed | Google Scholar

  7. Korir A, Yu Wang E, Sasieni P, Okerosi N, Ronoh V, Maxwell Parkin D. Cancer risks in Nairobi (2000-2014) by ethnic group. Int J Cancer. 2017;40(4):788-79. PubMed | Google Scholar

  8. Menon S, Wusiman A, Boily MC, Kariisa M, Mabeya H, Luchters S et al. Epidemiology of HPV genotypes among HIV positive women in Kenya: a systematic review and meta-analysis. PloS One. 2016;11(10):e0163965. PubMed | Google Scholar

  9. Menon SS, Rossi R, Harebottle R, Mabeya H, Vanden Broeck D. Distribution of human papillomaviruses and bacterial vaginosis in HIV positive women with abnormal cytology in Mombasa, Kenya. Infect Agent Cancer. 2016;11(1):17. PubMed | Google Scholar

  10. Jalilvand S, Shoja Z, Nourijelyani K, Tohidi HR, Hamkar R. Meta-analysis of type-specific human papillomavirus prevalence in Iranian women with normal cytology, precancerous cervical lesions and invasive cervical cancer: Implications for screening and vaccination. J Med Virol. 2015;87(2):287-295. PubMed | Google Scholar

  11. Hamkar R, Shoja Z, Ghavami N, Heydari N, Farahmand M, Jalilvand S. Type-Specific Human Papillomavirus Prevalence in Iranian Women with Normal Cervical Cytology: The Impact of Current HPV Vaccines. Intervirology. 2017;60(4):125-130. PubMed | Google Scholar

  12. Bruni L, Barrionuevo-Rosas L, Albero G, Aldea M, Serrano B, Valencia S. et al. ICO Information Centre on HPV and Cancer (HPV Information Centre), Human papillomavirus and related diseases in the world. Summary Rep. 2015;04-08.

  13. Grce M, Mravak-Stipetić M. Human papillomavirus-associated diseases. Clin Dermatol. 2014;32(2):253-258. PubMed | Google Scholar

  14. Yamada R, Sasagawa T, Kirumbi LW, Kingoro A, Karanja DK, Kiptoo M et al. Human papillomavirus infection and cervical abnormalities in Nairobi, Kenya, an area with a high prevalence of human immunodeficiency virus infection. J Med Virol. 2008;80(5):847-855. PubMed | Google Scholar

  15. Lemeshow S, Hosmer DW, Klar J, Lwanga SK, Organization WH. Adequacy of sample size in health studies. 1990. Google Scholar

  16. Singh AS, Masuku MB. Sampling techniques & determination of sample size in applied statistics research: An overview. International Journal of Economics, Commerce and Management. 2014;2(11):1-22.

  17. Adefuye PO, Broutet NJ, de Sanjosé S, Denny LA. Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa. Vaccine. 2013;31:F53-F59. PubMed | Google Scholar

  18. Sankaranarayanan R. Screening for cancer in low-and middle-income countries. Ann Glob Health. 2014;80(5):412-417. PubMed | Google Scholar

  19. Santesso N, Mustafa RA, Schünemann HJ, Arbyn M, Blumenthal PD, Cain J et al. World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer. Int J Gynaecol Obstet. 2016;132(3):252-258. PubMed | Google Scholar

  20. Masenya M. Liquid based cytology. In: Obstetrics and Gynaecology Forum: 2011: Sabinet; 2011: 9-11. Google Scholar

  21. de Bekker-Grob EW, de Kok IM, Bulten J, van Rosmalen J, Vedder JE, Arbyn M et al. Liquid-based cervical cytology using ThinPrep technology: weighing the pros and cons in a cost-effectiveness analysis. Cancer Causes & Control. 2012;23(8):1323-1331. PubMed | Google Scholar

  22. Temmerman M, Tyndall M, Kidula N, Claeys P, Muchiri L, Quint W. Risk factors for human papillomavirus and cervical precancerous lesions, and the role of concurrent HIV-1 infection. Int J Gynaecol Obstet. 1999;65(2):171-181. PubMed | Google Scholar

  23. Choudhary P, Sudhamani S, Pandit A, Kiri V. Comparison of modified ultrafast Papanicolaou stain with the standard rapid Papanicolaou stain in cytology of various organs. J Cytol. 2012;29(4):241. PubMed | Google Scholar

  24. Ikenberg H. Prophylaxis and early detection of HPV-related neoplasia. Materia medica. 2012;28(2):577-585. Google Scholar

  25. Cesar M, Pedroso LR, Altvater MC, Mikami L, Freitas-Lidani KC. Oncotic Cytology in the Prevention of Cervical Cancer. Animal biology journal. 1949:165. Google Scholar

  26. Organization WH. WHO prequalification of in vitro diagnostics public report. World Health Organization, Geneva, Switzerland. 2017.

  27. Organization WH. WHO prequalification of in vitro diagnostics public report. Product: Xpert® HIV-1 Qual assay. WHO reference number PQDx 0259-070-00.12. World Health Organization, Geneva, Switzerland 2016.

  28. Einstein MH, Smith KM, Davis TE, Schmeler KM, Ferris DG, Savage AH et al. Clinical evaluation of the cartridge-based GeneXpert human papillomavirus assay in women referred for colposcopy. J Clin Microbiol. 2014;52(6):2089-2095. PubMed | Google Scholar

  29. Rabaan AA, Taylor DR, Dawamneh MF, Al-Tawfiq JA. Comparison of Xpert® HPV and Hybrid Capture® 2 DNA TestTM for detection of high-risk HPV infection in cervical atypical squamous cells of undetermined significance. J Infect Public Health. 2017;10(2):219-223. PubMed | Google Scholar

  30. Nayar R, Wilbur DC. The pap test and Bethesda 2014. Acta cytologica. 2015;59(2):121-132. PubMed | Google Scholar

  31. Nayar R, Wilbur DC. The Bethesda System for reporting cervical cytology: a historical perspective. Acta cytologica. 2017;61(4-5):359-372. PubMed | Google Scholar

  32. Smith J. Bethesda 2001. Cytopathology. 2002;13(1):4-10. PubMed | Google Scholar

  33. Herraez-Hernandez E, Alvarez-Perez M, Navarro-Bustos G, Esquivias J, Alonso S, Aneiros-Fernandez J et al. HPV Direct Flow CHIP: A new human papillomavirus genotyping method based on direct PCR from crude-cell extracts. J Virol Methods. 2013;193(1):9-17. PubMed | Google Scholar

  34. Tangjitgamol S, Kantathavorn N, Kittisiam T, Chaowawanit W, Phoolcharoen N, Manusirivithaya S et al. Prevalence and associated factors of abnormal cervical cytology and high risk HPV DNA among Bangkok metropolitan women. Asian Pac J Cancer Prev. 2016;17(7):3147-3153. PubMed | Google Scholar

  35. Ngugi C, Schmidt D, Wanyoro R, Boga H, Wanzala P, Muigai A et al. Prevalence of human papillomavirus infection by age and cervical cytology in Thika Kenya. African Journal of Health Sciences. 2011;19(3-4):53-62. Google Scholar

  36. Dainty EE. Screening for Cervical Cancer in HIV Positive Kenyan Women: the Role of HPV Genotyping. Duke University. 2013. Google Scholar

  37. Pawelec G. Age and immunity: what is “immunosenescence”. Experimental gerontology. 2018;105:4-9. PubMed | Google Scholar

  38. Montealegre J, Peckham-Gregory E, Marquez-Do D, Dillon L, Guillaud M, Adler-Storthz K et al. Racial/ethnic differences in HPV 16/18 genotypes and integration status among women with a history of cytological abnormalities. Gynecologic oncology. 2018; 148(2):357-362. PubMed | Google Scholar

  39. Orozco-Colín A, Carrillo-García A, Méndez-Tenorio A, Ponce-de-León S, Mohar A, Maldonado-Rodríguez R et al. Geographical variation in human papillomavirus prevalence in Mexican women with normal cytology. Int J Infect Dis. 2010;14(12):e1082-e1087. PubMed | Google Scholar

  40. Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. International journal of cancer. 2011;128(4):927-935. PubMed | Google Scholar

  41. Ghedira R, Mahfoudh W, Hadhri S, Gabbouj S, Bouanene I, Khairi H et al. Human papillomavirus genotypes and HPV-16 variants distribution among Tunisian women with normal cytology and squamous intraepithelial lesions. nfect Agent Cancer. 2016;11(1):61. PubMed | Google Scholar

  42. Akarolo-Anthony SN, Famooto AO, Dareng EO, Olaniyan OB, Offiong R, Wheeler CM et al. Age-specific prevalence of human papilloma virus infection among Nigerian women. BMC public health. 2014;14(1):656. PubMed | Google Scholar

  43. Shanaka K, Wilathgamuwa S, Gunawardene Y, Dassanayake R. Prevalence of human papilloma virus and their high-risk genotypes in Sri Lankan women. Virusdisease. 2018;29(1):27-31. PubMed | Google Scholar

  44. Cutilli T, Leocata P, Dolo V, Altobelli E. Association between p53 status, human papillomavirus infection, and overall survival in advanced oral cancer after resection and combination systemic treatment. Br J Oral Maxillofac Surg. 2016;54(2):198-202. PubMed | Google Scholar

  45. Tangjitgamol S, Tangjitgamol S, Kantathavorn N, Phoolcharoen N, Kittisiam T, Chaowawanit W et al. Prevalence of abnormal cervical cytology and HPV DNA test among Bangkok metropolitan women. In: International journal of gynecological cancer: 2015: Lippincott Williams & Wilkins two commerce sq, 2001 market ST, Philadelphia. 2015: 1000-1000.

  46. Bansal D, Elmi AA, Skariah S, Haddad P, Abu-Raddad LJ, Al Hamadi AH et al. Molecular epidemiology and genotype distribution of Human Papillomavirus (HPV) among Arab women in the State of Qatar. J Transl Med. 2014;12(1):300. PubMed | Google Scholar

  47. Qiong J, Keng S, Hui L, Zhou X-r, Huang H-f, Leng J-h. Age-specific prevalence of human papillomavirus by grade of cervical cytology in Tibetan women. Chinese medical journal. 2010;123(15):2004-2011. Google Scholar

  48. Sabol I, Gašperov NM, Matovina M, Božinović K, Grubišić G, Fistonić I et al. Cervical HPV type-specific pre-vaccination prevalence and age distribution in Croatia. PloS One. 2017;12(7):e0180480. PubMed | Google Scholar